Cite
HARVARD Citation
Combe, B. et al. (n.d.). OA29 Clinical outcomes up to week 48 of filgotinib treatment in an ongoing long-term extension trial of RA patients with inadequate response to methotrexate initially treated with filgotinib or adalimumab during the Phase 3 Parent Trial. Rheumatology. p. . [Online].